0001209191-20-038471.txt : 20200623 0001209191-20-038471.hdr.sgml : 20200623 20200623163011 ACCESSION NUMBER: 0001209191-20-038471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200622 FILED AS OF DATE: 20200623 DATE AS OF CHANGE: 20200623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashton William CENTRAL INDEX KEY: 0001474553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 20982523 MAIL ADDRESS: STREET 1: C/O HARRISON CONSULTING GROUP STREET 2: PO BOX 283 CITY: NEWTOWN SQUARE STATE: PA ZIP: 19073 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-22 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001474553 Ashton William 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 1 0 0 0 Common Stock, $0.001 par value 2020-06-22 4 S 0 5000 3.25 D 41666 D Stock Option (Right to Buy) 2.94 2020-06-18 4 A 0 60000 0.00 A 2030-06-18 Common Stock 60000 60000 D All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer. This stock option grant was previously reported on a Form 4 on June 19, 2020. This is an amendment to that Form 4 to reflect an inadvertent error in Column 7 under the "Amount or Number of Shares". One third of the aggregate amount of option shares shall vest on each of June 18, 2021, 2022 and 2023, respectively. /s/ Kurt A. Gustafson, attorney-in-fact for William L. Ashton 2020-06-23